dc.contributor.author
Hamann, Lutz
dc.contributor.author
Bustami, Jasmin
dc.contributor.author
Iakoubov, Leonid
dc.contributor.author
Szwed, Malgorzata
dc.contributor.author
Mossakowska, Malgorzata
dc.contributor.author
Schumann, Ralf R.
dc.contributor.author
Puzianowska-Kuznicka, Monika
dc.date.accessioned
2018-06-08T03:13:28Z
dc.date.available
2016-04-21T08:44:20.547Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/14709
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-18899
dc.description.abstract
Background To investigate mechanisms that determine healthy aging is of major
interest in the modern world marked by longer life expectancies. In addition
to lifestyle and environmental factors genetic factors also play an important
role in aging phenotypes. The aged immune system is characterized by a chronic
micro-inflammation, known as inflamm-aging, that is suspected to trigger the
onset of age-related diseases such as cardiovascular disease, Alzheimer’s
disease, cancer, and Diabetes Mellitus Type 2 (DMT2). We have recently shown
that a Toll-like receptor 6 variant (P249S) is associated with susceptibility
to cardiovascular disease and speculated that this variant may also be
associated with healthy aging in general by decreasing the process of inflamm-
aging. Results Analyzing the PolSenior cohort we show here that nonsmoking S
allele carriers are significantly protected from age-related diseases (P =
0.008, OR: 0.654). This association depends not only on the association with
cardiovascular diseases (P = 0.018, OR: 0.483) for homozygous S allele
carriers, but is also driven by a protection from Diabetes Mellitus type 2 (P
= 0.010, OR: 0.486) for S allele carriers. In addition we detect a trend but
no significant association of this allele with inflamm-aging in terms of
baseline IL-6 levels. Conclusion We confirm our previous finding of the TLR-6
249S variant to be protective regarding cardiovascular diseases. Furthermore,
we present first evidence of TLR-6 249S being involved in DMT2 susceptibility
and may be in general associated with healthy aging possibly by reducing the
process of inflamm-aging.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Toll-like receptor 6
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
TLR-6 SNP P249S is associated with healthy aging in nonsmoking Eastern
European Caucasians - A cohort study
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Immunity & Ageing. - 13 (2016), Artikel Nr. 7
dcterms.bibliographicCitation.doi
10.1186/s12979-016-0062-3
dcterms.bibliographicCitation.url
http://immunityageing.biomedcentral.com/articles/10.1186/s12979-016-0062-3
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000024410
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000006318
dcterms.accessRights.openaire
open access